HEALTH & FITNESS
Cancer cells deploy 'drones' to battle immune system
Cancer cells release biological "drones" to attack and tire the immune system before the latter gets a chance to fight off tumours, say scientists.
The study, published in the journal Nature, shows that far for being just a lump of cells growing out of control, cancer cells participate in active combat with the immune system for their own survival.
The small vesicles called exosomes circulating in the blood and armed with proteins called PD-L1 that cause T cells to tire before they have a chance to reach the tumour and do battle, according to researchers from the University of Pennsylvania in the US.
While primarily focused on metastatic melanoma, the team found that breast and lung cancer also release the PD-L1-carrying exosomes.
The research offers a paradigm-shifting picture of how cancers take a systemic approach to suppressing the immune system.
In addition, it also points to a new way to predict which cancer patients will respond to anti-PD1 therapy that disrupts immune suppression to fight tumours and a means of tracking the effectiveness of such therapies.
"Immunotherapies are life-saving for many patients with metastatic melanoma, but about 70 per cent of these patients don't respond," said Wei Guo, a professor at University of Pennsylvania.
"These treatments are costly and have toxic side effects so it would be very helpful to know which patients are going to respond," said Guo.
"Identification of a biomarker in the bloodstream could potentially help make early predictions about which patients will respond, and, later on, could offer patients and their doctors a way to monitor how well their treatment is working," he said.
One of the most successful innovations in cancer therapy has been the use of checkpoint inhibitor drugs, which are designed to block attempts by cancer cells to suppress the immune system to allow tumours to thrive and spread.
One of the primary targets for this class of drugs is PD-1, a protein on the surface of T cells. On tumour cells, they express a counterpart molecule called PD-L1, which interacts with the PD-1 protein on T cells, effectively turning off that cell's anti-cancer response.
Blocking that interaction using checkpoint inhibitors reinvigorates T cells, allowing them to unleash their cancer-killing power on the tumour.
While it was known that cancer cells carried PD-L1 on their surface, researchers found that exosomes from human melanoma cells also carried PD-L1 on their surface.
Exosomal PD-L1 can directly bind to and inhibit T cell functions. Identification of the exosomal PD-L1 secreted by tumour cells provides a major update to the immune checkpoint mechanism, and offers novel insight into tumour immune evasion.
- Resistance training boosts motivation to exercise 19 Aug 2018 | PTI
- YouTube videos on plastic surgery spreading misinformation: Study 19 Aug 2018 | PTI
- US varsity signs MoU with Indian Nursing Council 19 Aug 2018 | PTI
- Brain tumours may occur in children with common genetic syndrome 18 Aug 2018 | IANS
- Higher BMI may increase your BP as well 18 Aug 2018 | IANS
- Delhi official wins WHO award on tobacco control initiative 18 Aug 2018 | PTI
- Smartphone screens harbour more germs than a toilet seat: Study 18 Aug 2018 | IANS
- IRDAI asks Insurance firms to cover mental illness in policies 18 Aug 2018 | PTI
- Birth control app highlights emerging health tech market 17 Aug 2018 | AP
- Doctors Without Borders welcomes WHO's new recommendations to treat drug-resistant TB 17 Aug 2018 | PTI
Sunday EditionView All
19 Aug 2018 | Kumar Chellappan
A succession war is brewing in the DMK after Karunanidhi’s death, with both Stalin and Alagiri staking a claim to their father’s political legacy. This, along with the churning in the AIADMK after Jayalalithaa’s death, is bound to have an impact on the political landscape of Tamil Nadu in the run-up to 2019 Lok Sabha polls, writes Kumar Chellappan Tamil Nadu politics sans Muthuvel Karunanidhi is like the drama Hamlet without...
STATE EDITIONSView All
19 Aug 2018 | PNS | Ranchi
Yet another girl from the Capital City Khushboo Vijay became the winner of Miss India International Global 2018 and will be representing India next year in Malaysia 2019 for World Finale. The event was held in Guwahati on August 2018...